Ryvu Therapeutics S.A.
WSE:RVU.WA
64.5 (PLN) • At close December 14, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) PLN.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||
| Current Assets: | |||||||||||||||
| Cash & Cash Equivalents
| 160.073 | 57.939 | 101.917 | 83.236 | 136.218 | 72.107 | 110.374 | 36.124 | 29.095 | 28.807 | 4.758 | 5.298 | 5.128 | 6.959 | 0.329 |
| Short Term Investments
| 65.326 | 175.733 | 0.528 | 4.994 | 24.969 | 0 | -0.196 | -0.196 | 0 | 0 | 0.12 | 0.12 | -0.162 | -0.098 | 0 |
| Cash and Short Term Investments
| 225.399 | 233.672 | 101.917 | 88.229 | 161.188 | 72.107 | 110.374 | 36.124 | 29.095 | 28.807 | 4.878 | 5.418 | 5.128 | 6.959 | 0.329 |
| Net Receivables
| 20.916 | 9.187 | 1.045 | 11.741 | 7.948 | 15.041 | 21.353 | 19.765 | 16.38 | 17.961 | 10.314 | 4.849 | 1.73 | 0 | 0 |
| Inventory
| 1.21 | 2.118 | 1.759 | 1.957 | 1.676 | 1.586 | 1.989 | 1.591 | 1.403 | 1.174 | 0.706 | 0.391 | 0.346 | 0.327 | 0.319 |
| Other Current Assets
| 24.911 | 33.416 | 262.681 | 8.117 | 7.299 | 14.635 | 39.889 | 2.393 | 0.791 | 0.582 | 1.411 | 0.532 | 0.89 | 2.812 | 1.904 |
| Total Current Assets
| 272.436 | 278.393 | 367.93 | 104.248 | 172.362 | 89.976 | 173.218 | 59.873 | 47.669 | 48.524 | 17.31 | 11.191 | 8.094 | 10.098 | 2.552 |
| Non-Current Assets: | |||||||||||||||
| Property, Plant & Equipment, Net
| 72.734 | 77.554 | 82.219 | 91.182 | 91.162 | 66.189 | 51.07 | 31.377 | 21.833 | 8.597 | 6.845 | 9.367 | 5.083 | 5.173 | 5.424 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0.281 | 0.281 | 0.281 | 0.281 | 0.281 | 0.281 | 0.04 | 0 | 0 |
| Intangible Assets
| 8.116 | 6.337 | 4.276 | 3.044 | 2.319 | 2.924 | 2.403 | 2.357 | 6.36 | 1.993 | 0.05 | 0.001 | 0.005 | 0 | 0 |
| Goodwill and Intangible Assets
| 8.116 | 6.337 | 4.276 | 3.044 | 2.319 | 2.924 | 2.684 | 2.638 | 6.64 | 2.274 | 0.331 | 0.001 | 0.045 | 0.311 | 0.691 |
| Long Term Investments
| -48.552 | 16.904 | 20.475 | 24.41 | 4.149 | 23.754 | 23.022 | 2.235 | 3.121 | 0 | 0.19 | 0.162 | 0.437 | 0.294 | -0.691 |
| Tax Assets
| 65.328 | 0 | -20.475 | 0.331 | 0.594 | 0.701 | 4.336 | 7.451 | 9.663 | 5.651 | 2.128 | 1.692 | 1.692 | 1.629 | 1.439 |
| Other Non-Current Assets
| 74.043 | 24.014 | 20.552 | 5.597 | 25.055 | -0.651 | 1.369 | 0 | 0.196 | 0.196 | 0 | -4.435 | -0.002 | 0 | 0.853 |
| Total Non-Current Assets
| 106.341 | 124.809 | 107.047 | 124.565 | 123.278 | 92.917 | 82.482 | 43.701 | 41.452 | 16.718 | 9.494 | 6.787 | 7.254 | 7.406 | 7.717 |
| Total Assets
| 378.777 | 403.202 | 474.977 | 228.813 | 295.64 | 182.893 | 255.7 | 103.574 | 89.121 | 65.242 | 26.803 | 17.977 | 15.348 | 17.504 | 10.269 |
| Liabilities & Equity: | |||||||||||||||
| Current Liabilities: | |||||||||||||||
| Account Payables
| 31.15 | 23.142 | 12.579 | 11.689 | 6.261 | 13.35 | 16.69 | 9.365 | 6.79 | 3.906 | 5.363 | 3.098 | 1.85 | 1.681 | 1.615 |
| Short Term Debt
| 0.791 | 0.541 | 1.903 | 2.751 | 3.082 | 3.299 | 2.237 | 1.824 | 1.804 | 0.302 | 0.458 | 0.321 | 0 | 0 | 0 |
| Tax Payables
| 2.226 | 1.962 | 0.992 | 6.676 | 0.667 | 0.229 | 3.017 | 1.583 | 1.093 | 0.025 | 0.693 | 0.377 | 0.487 | 0 | 0 |
| Deferred Revenue
| 0 | 25.305 | 13.624 | 19.261 | 19.869 | 6.763 | 3.017 | 1.583 | 10.162 | 11.005 | 8.11 | 8.096 | 0 | 0 | 0 |
| Other Current Liabilities
| 73.761 | 18.753 | 15.716 | 15.084 | 23.803 | 6.975 | 13.624 | 5.15 | 3.6 | 4.702 | 4.141 | 7.605 | 5.04 | 2.223 | 4.9 |
| Total Current Liabilities
| 107.928 | 69.703 | 44.814 | 36.2 | 33.813 | 30.596 | 35.568 | 26.752 | 18.933 | 16.319 | 15.271 | 11.361 | 7.378 | 3.904 | 6.514 |
| Non-Current Liabilities: | |||||||||||||||
| Long Term Debt
| 74.723 | 0.365 | 0.865 | 2.318 | 4.327 | 5.918 | 5.896 | 6.17 | 7.82 | 0.298 | 0.177 | 0.109 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 42.738 | 0 | 75.803 | 20.257 | 27.503 | 0.1 | 10.503 | 4.233 | 6.382 | 1.513 | 2.01 | -0.109 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0.438 | 6.042 | 5.144 | 4.575 | 0.526 | 0.214 | 0.17 | 0.064 | 0.096 | 0.096 | 0.032 | 0.015 |
| Other Non-Current Liabilities
| 9.504 | 73.542 | 85.906 | 28.993 | 6.277 | 0.188 | 4.583 | 1.897 | 0.061 | 0.061 | 0.027 | 0.027 | 2.342 | 0.081 | 2.238 |
| Total Non-Current Liabilities
| 126.965 | 73.907 | 86.771 | 23.192 | 38.106 | 32.537 | 25.272 | 12.826 | 14.477 | 2.043 | 2.278 | 3.488 | 2.438 | 2.138 | 2.253 |
| Total Liabilities
| 234.893 | 143.61 | 131.585 | 59.392 | 71.92 | 63.133 | 60.84 | 39.578 | 33.41 | 18.362 | 17.55 | 14.849 | 9.815 | 6.042 | 8.767 |
| Equity: | |||||||||||||||
| Preferred Stock
| 0 | 0 | 35.117 | 300.987 | 324.224 | 310.245 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 9.248 | 9.248 | 7.342 | 7.342 | 7.342 | 6.388 | 6.388 | 5.508 | 5.377 | 5.246 | 4.185 | 4.185 | 4.185 | 4.185 | 3.105 |
| Retained Earnings
| -111.444 | -0.01 | 92.103 | 184.005 | 261.539 | 292.407 | -6.518 | 1.379 | -0.92 | 3.479 | 0.663 | -5.462 | -13.082 | -7.153 | -2.714 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -269.394 | -35.117 | -300.987 | -324.224 | -310.245 | 37.139 | 29.93 | 25.437 | 12.439 | 1.883 | 1.883 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 246.08 | 519.748 | 279.063 | 279.063 | 279.063 | -475.302 | 200.994 | 44.129 | 40.371 | 25.284 | 0 | 2.247 | 14.429 | 0.499 | 1.111 |
| Total Shareholders Equity
| 143.884 | 259.592 | 343.392 | 169.422 | 223.721 | 119.76 | 191.913 | 62.298 | 55.375 | 46.448 | 9.254 | 3.129 | 5.533 | 11.462 | 1.502 |
| Total Equity
| 143.884 | 259.592 | 343.392 | 169.422 | 223.721 | 119.76 | 194.86 | 63.996 | 55.711 | 46.88 | 9.254 | 3.129 | 5.533 | 11.462 | 1.502 |
| Total Liabilities & Shareholders Equity
| 378.777 | 403.202 | 474.977 | 228.813 | 295.64 | 182.893 | 255.7 | 103.574 | 89.121 | 65.242 | 26.803 | 17.977 | 15.348 | 17.504 | 10.269 |